DE3876496D1 - Synthetisches peptid-antigen fuer nachweis von hiv-2-infektionen. - Google Patents

Synthetisches peptid-antigen fuer nachweis von hiv-2-infektionen.

Info

Publication number
DE3876496D1
DE3876496D1 DE8888850167T DE3876496T DE3876496D1 DE 3876496 D1 DE3876496 D1 DE 3876496D1 DE 8888850167 T DE8888850167 T DE 8888850167T DE 3876496 T DE3876496 T DE 3876496T DE 3876496 D1 DE3876496 D1 DE 3876496D1
Authority
DE
Germany
Prior art keywords
hiv
infection
synthetic peptide
peptide antigens
detecting hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888850167T
Other languages
English (en)
Other versions
DE3876496T2 (de
Inventor
Anders Vahlne
Bo Svennerholm
Lars Rymo
Stig Jeansson
Peter Horal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntello AB
Original Assignee
Syntello AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntello AB filed Critical Syntello AB
Publication of DE3876496D1 publication Critical patent/DE3876496D1/de
Application granted granted Critical
Publication of DE3876496T2 publication Critical patent/DE3876496T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE8888850167T 1987-05-18 1988-05-13 Synthetisches peptid-antigen fuer nachweis von hiv-2-infektionen. Expired - Fee Related DE3876496T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/051,727 US4812556A (en) 1987-05-18 1987-05-18 Synthetic peptide antigen for the detection of HIV-2 infection

Publications (2)

Publication Number Publication Date
DE3876496D1 true DE3876496D1 (de) 1993-01-21
DE3876496T2 DE3876496T2 (de) 1993-05-13

Family

ID=21973023

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888850167T Expired - Fee Related DE3876496T2 (de) 1987-05-18 1988-05-13 Synthetisches peptid-antigen fuer nachweis von hiv-2-infektionen.

Country Status (11)

Country Link
US (1) US4812556A (de)
EP (1) EP0292454B1 (de)
AT (1) ATE83247T1 (de)
AU (1) AU606951B2 (de)
DE (1) DE3876496T2 (de)
DK (1) DK268588A (de)
ES (1) ES2011334A6 (de)
FI (1) FI882173A (de)
NO (1) NO881719L (de)
NZ (1) NZ224581A (de)
ZA (1) ZA883431B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701628D0 (sv) * 1987-04-16 1987-04-16 Erling Norrby Medel for analys mm
US5019387A (en) * 1987-09-08 1991-05-28 Duke University Production of antibodies to HIV
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
EP0316695B1 (de) * 1987-11-16 1993-03-31 F. Hoffmann-La Roche Ag Rekombinante HIV-2 Polypeptide
US5780038A (en) * 1987-11-16 1998-07-14 Roche Diagnostic Systems, Inc. HIV-2 envelope polypeptides
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6214537B1 (en) * 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
WO1989009785A1 (en) * 1988-04-07 1989-10-19 The Trustees Of The University Of Alabama Peptides inhibitors of hiv induced cell fusions and syncytia formation
EP0362927A3 (de) * 1988-10-06 1990-11-14 Akzo N.V. Mit HIV-Antikörpern immunochemisch reaktive synthetische Polypeptide
AU641375B2 (en) * 1988-12-20 1993-09-23 Clarity Technologies Incorporated Synthetic HIV-like peptides, their compositions and uses
US5260189A (en) * 1988-12-20 1993-11-09 Immunodiagnostics, Inc. Synthetic HIV-like peptides their compositions and uses
CA2017021A1 (en) * 1989-05-22 1990-11-22 Johannes Jacobus Schalken Diagnostic test for detecting antibodies directed against antigens of one or more related viruses
JPH0338599A (ja) * 1989-07-05 1991-02-19 Calpis Food Ind Co Ltd:The 抗ｈｉｖペプチド及び抗ｈｉｖ修飾ペプチド
US6083504A (en) * 1989-08-24 2000-07-04 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1)
US6008044A (en) * 1989-08-24 1999-12-28 Bioclonetics Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) and detection of antibodies against epitope (GCSGKLIC)
US5459060A (en) * 1989-08-24 1995-10-17 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
DE69129207T2 (de) * 1990-01-16 1998-10-08 Orgenics Ltd Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
CA2099367A1 (en) * 1991-11-04 1993-05-05 Dade International Inc. Synthetic peptides corresponding to portions of hiv-2 virus and methods of using in an improved assay
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US5420244A (en) * 1993-08-06 1995-05-30 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for diagnosing HTLV-I associated myelopathy and adult T-cell leukemia
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
US7229841B2 (en) * 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US6407218B1 (en) 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
US6537631B1 (en) * 1999-04-30 2003-03-25 Kimberly-Clark Worldwide, Inc. Roll of wet wipes
EP1423749B1 (de) * 2001-09-04 2009-08-05 Wisconsin Alumni Research Foundation Flüssigkristallumschaltmechanismus
AU2002341900A1 (en) * 2001-10-04 2003-04-14 Wisconsin Alumni Research Foundation Detection of dna hybridization on surfaces
US7807348B2 (en) * 2002-03-20 2010-10-05 Wisconsin Alumni Research Foundation Optical imaging of nanostructured substrates
US7125592B2 (en) * 2002-04-10 2006-10-24 Wisconsin Alumni Research Foundation Detecting interactions at biomimetic interfaces with liquid crystals
WO2004044583A1 (en) * 2002-11-08 2004-05-27 Wisconsin Alumni Research Foundation Surfaces with gradients in surface topography
US7303694B2 (en) * 2003-07-17 2007-12-04 Wisconsin Alumni Research Foundation Liquid crystals with reduced toxicity and applications thereof
US20050175583A1 (en) * 2003-12-02 2005-08-11 Lawrence Tamarkin Methods and compositions for the production of monoclonal antibodies
EP1715971A4 (de) * 2004-01-28 2010-10-13 Cytimmune Sciences Inc Funktionalisierte kolloidale metallzusammensetzungen und verfahren
US7910382B2 (en) * 2005-10-31 2011-03-22 Wisconsin Alumni Research Foundation Device and methods for liquid crystal-based bioagent detection
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
CA2700378A1 (en) * 2007-09-21 2009-03-29 Cytimmune Sciences, Inc. Nanotherapeutic colloidal metal compositions and methods
US7960145B2 (en) * 2007-11-08 2011-06-14 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies
US20130306629A1 (en) * 2012-05-21 2013-11-21 Hanna Asfaw Unity Cup

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE47725T1 (de) * 1986-01-22 1989-11-15 Pasteur Institut Zum hervorrufen von aids geeigneter retrovirus vom typ hiv-2, sowie seine antigen- und nukleinsaeure-bestandteile.

Also Published As

Publication number Publication date
EP0292454B1 (de) 1992-12-09
ES2011334A6 (es) 1990-01-01
ATE83247T1 (de) 1992-12-15
FI882173A (fi) 1988-11-19
NO881719D0 (no) 1988-04-21
DK268588A (da) 1988-11-19
FI882173A0 (fi) 1988-05-10
NO881719L (no) 1988-11-21
AU606951B2 (en) 1991-02-21
US4812556A (en) 1989-03-14
NZ224581A (en) 1990-09-26
AU1645688A (en) 1988-11-24
EP0292454A2 (de) 1988-11-23
ZA883431B (en) 1988-11-17
EP0292454A3 (en) 1989-10-04
DK268588D0 (da) 1988-05-17
DE3876496T2 (de) 1993-05-13

Similar Documents

Publication Publication Date Title
DE3876496T2 (de) Synthetisches peptid-antigen fuer nachweis von hiv-2-infektionen.
ATE107663T1 (de) Synthetische peptidantigene zum nachweis von htlv-1-infektionen.
ES2013328A6 (es) Un metodo para detectar anticuerpos contra antigenos hiv-1.
ATE364621T1 (de) Hiv-peptide
DE69013950T2 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
NO173958C (no) Fremgangsmaate for paavisning av tilstedevaerelse av antistoff mot HIV-virus
DE3672624D1 (de) Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.
SE8902148L (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
GR3033885T3 (en) Synthetic antigens for the detection of aids-related disease caused by LAV-2.
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
DE69026875T2 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee